Trial Profile
A retrospective, observational study of Buprenoprhine/Naloxone patients with opioid dependence in general practice settings
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Oct 2017
Price :
$35
*
At a glance
- Drugs Buprenorphine/naloxone (Primary) ; Buprenorphine; Methadone
- Indications Opioid-related disorders
- Focus Adverse reactions
- 17 Oct 2017 New trial record
- 12 Oct 2017 Results presented at the 20th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research